πŸ‡ΊπŸ‡Έ FDA
Patent

US 8461348

Heterocyclic derivative and use thereof

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8461348 (Heterocyclic derivative and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/06, A61P1/14